PeptideDB

Ethanone,1-[4-[2-hydroxy-3-(5-quinolinyloxy)propyl]-1-piperazinyl]-2,2-diphenyl- 129716-58-1

Ethanone,1-[4-[2-hydroxy-3-(5-quinolinyloxy)propyl]-1-piperazinyl]-2,2-diphenyl- 129716-58-1

CAS No.: 129716-58-1

Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiti
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.

Physicochemical Properties


Molecular Formula C30H31N3O3
Molecular Weight 481.58544
Exact Mass 481.237
CAS # 129716-58-1
PubChem CID 213040
Density 1.228g/cm3
Boiling Point 720.8ºC at 760mmHg
Flash Point 389.7ºC
Vapour Pressure 8.36E-22mmHg at 25°C
Index of Refraction 1.64
LogP 3.826
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 8
Heavy Atom Count 36
Complexity 652
Defined Atom Stereocenter Count 0
SMILES

OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3

InChi Key KLWUUPVJTLHYIM-UHFFFAOYSA-N
InChi Code

InChI=1S/C30H31N3O3/c34-25(22-36-28-15-7-14-27-26(28)13-8-16-31-27)21-32-17-19-33(20-18-32)30(35)29(23-9-3-1-4-10-23)24-11-5-2-6-12-24/h1-16,25,29,34H,17-22H2
Chemical Name

1-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-2,2-diphenylethanone

Biological Activity


References

[1]. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. Clin Cancer Res. 2002 Feb;8(2):582-8.

[2]. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells. Jpn J Cancer Res. 2001 Jul;92(7):785-92.

[3]. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines. Oncol Res. 1997;9(2):61-9.

Additional Infomation Dofequidar is an antineoplastic agent.
Dofequidar is an orally-available synthetic quinoline derivative with multidrug resistance modulating properties. Dofequidar binds to the drug-binding site of the transmembrane P-glycoprotein efflux pump and is preferentially transported from the cell, thereby blocking the efflux of other therapeutic agents.

Solubility Data


Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0765 mL 10.3823 mL 20.7646 mL
5 mM 0.4153 mL 2.0765 mL 4.1529 mL
10 mM 0.2076 mL 1.0382 mL 2.0765 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.